Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Lucid Diagnostics (LUCD) Receivables - Other (2020 - 2023)

Lucid Diagnostics filings provide 4 years of Receivables - Other readings, the most recent being $10.7 million for Q2 2023.

  • On a quarterly basis, Receivables - Other rose 340.39% to $10.7 million in Q2 2023 year-over-year; TTM through Jun 2023 was $10.7 million, a 340.39% increase, with the full-year FY2022 number at $5.0 million, up 199.34% from a year prior.
  • Receivables - Other hit $10.7 million in Q2 2023 for Lucid Diagnostics, up from $7.6 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $13.3 million in Q4 2020 to a low of $1.7 million in Q4 2021.
  • Median Receivables - Other over the past 4 years was $5.8 million (2022), compared with a mean of $6.1 million.
  • Biggest five-year swings in Receivables - Other: crashed 87.5% in 2021 and later skyrocketed 340.39% in 2023.
  • Lucid Diagnostics' Receivables - Other stood at $13.3 million in 2020, then crashed by 87.5% to $1.7 million in 2021, then skyrocketed by 199.34% to $5.0 million in 2022, then surged by 115.67% to $10.7 million in 2023.
  • The last three reported values for Receivables - Other were $10.7 million (Q2 2023), $7.6 million (Q1 2023), and $5.0 million (Q4 2022) per Business Quant data.